$1.66
0.010.61%
Last update: Oct 20, 8:00 PM
Serina Therapeutics Inc
SERAMEX
Serina Therapeutics (SER) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.35 | $-0.44 | $-0.47 | $-0.51 |
| Actual | $-0.55 | $-0.58 | $-0.31 | $-0.45 |
| Surprise | -57.1% | -31.8% | +34.0% | +11.8% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $130000 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.34 | $-0.30 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.55 | $-0.35 | -57.1 % |
| Q1 | May 14, 2026 | $-0.58 | $-0.44 | -31.8 % |
| Q4 | Mar 25, 2026 | $-0.31 | $-0.47 | 34.0 % |
| Q3 | Nov 13, 2025 | $-0.45 | $-0.51 | 11.8 % |
